Chan A - Search Results

1

Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysis.

Bagnoud M, Remlinger J, Joly S, Massy M, Salmen A, Chan A, Karathanassis D, Evangelopoulos ME, Hoepner R. Bagnoud M, et al. Among authors: chan a. CNS Neurosci Ther. 2024 Feb;30(2):e14484. doi: 10.1111/cns.14484. Epub 2023 Oct 10. CNS Neurosci Ther. 2024. PMID: 37817393 Free PMC article.

2

The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data.

Salmen A, Marti S, Hoepner AGF, Chan A, Hoepner R. Salmen A, et al. Among authors: chan a. Front Pharmacol. 2023 Jun 15;14:1186404. doi: 10.3389/fphar.2023.1186404. eCollection 2023. Front Pharmacol. 2023. PMID: 37397473 Free PMC article.

3

Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations.

Remlinger J, Bagnoud M, Meli I, Massy M, Hoepner R, Linington C, Chan A, Bennett JL, Enzmann V, Salmen A. Remlinger J, et al. Among authors: chan a. Neurol Neuroimmunol Neuroinflamm. 2023 Jul 10;10(5):e200141. doi: 10.1212/NXI.0000000000200141. Print 2023 Sep. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37429715 Free PMC article.

4

Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations.

Remlinger J, Bagnoud M, Meli I, Massy M, Linington C, Chan A, Bennett JL, Hoepner R, Enzmann V, Salmen A. Remlinger J, et al. Among authors: chan a. Mult Scler Relat Disord. 2023 Oct;78:104892. doi: 10.1016/j.msard.2023.104892. Epub 2023 Jul 17. Mult Scler Relat Disord. 2023. PMID: 37499337 Free article.

5

Nogo-A antibody delivery through the olfactory mucosa mitigates experimental autoimmune encephalomyelitis in the mouse CNS.

Pernet V, Joly S, Spiegel S, Meli I, Idriss S, Maigler F, Mdzomba JB, Roenneke AK, Franceschini A, Silvestri L, Pavone FS, Calamai M, Schindowski K, Chan A. Pernet V, et al. Among authors: chan a. Cell Death Discov. 2023 Aug 9;9(1):290. doi: 10.1038/s41420-023-01588-7. Cell Death Discov. 2023. PMID: 37558696 Free PMC article.

6

Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: Real-world experience of two Swiss multiple sclerosis centers.

Diem L, Ovchinnikov A, Friedli C, Hammer H, Kamber N, Chan A, Salmen A, Findling O, Hoepner R. Diem L, et al. Among authors: chan a. Mult Scler Relat Disord. 2024 Jun;86:105570. doi: 10.1016/j.msard.2024.105570. Epub 2024 Mar 30. Mult Scler Relat Disord. 2024. PMID: 38604001 Free article.

7

Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study.

Friedli C, Krajnc N, Hammer HN, Marti S, Zrzavy T, Evangelopoulos ME, Kapsali I, Rommer P, Berger T, Chan A, Bsteh G, Hoepner R. Friedli C, et al. Among authors: chan a. J Cent Nerv Syst Dis. 2024 May 5;16:11795735241249644. doi: 10.1177/11795735241249644. eCollection 2024. J Cent Nerv Syst Dis. 2024. PMID: 38711956 Free PMC article.

8

The effect of standardization of insertion and removal of percutaneous left ventricular assist device.

Lee J, Gondi S, Gifft K, Wang J, Bhattad V, Bavishi C, Karuparthi PR, Kumar A, Chan A, Matsukage H, Hirai T. Lee J, et al. Among authors: chan a. Cardiovasc Revasc Med. 2024 May 31:S1553-8389(24)00515-3. doi: 10.1016/j.carrev.2024.05.035. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38845282

9

Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors.

Yusuf R, Ng DQ, Torno L, Chan A. Yusuf R, et al. Among authors: chan a. Curr Opin Oncol. 2024 Jul 1;36(4):211-222. doi: 10.1097/CCO.0000000000001033. Epub 2024 Feb 26. Curr Opin Oncol. 2024. PMID: 38842014 Review.

10

Impact of a Multidisciplinary Supportive Care Model Using Distress Screening at an Asian Ambulatory Cancer Center: A Cluster Randomized Controlled Trial.

Ke Y, Neo PSH, Yang GM, Neo SH, Tan YY, Tan YP, Ramalingam MB, Loh KW, Quah DSC, Chew L, Si PEH, Chan RJ, Hwang WYK, Chan A. Ke Y, et al. Among authors: chan a. JCO Oncol Pract. 2024 Jun 5:OP2300505. doi: 10.1200/OP.23.00505. Online ahead of print. JCO Oncol Pract. 2024. PMID: 38838278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,114 results

Search Page